(paliperidone palmitate)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Last Updated: 02/10/2025
Abbreviations: IM, intramuscular.
a
INVEGA TRINZA is supplied in prefilled syringes with a concentration of 312 mg/mL of paliperidone palmitate.2
Strength | Volume | NDC # |
---|---|---|
273 mg paliperidone palmitate | 0.88 mL | 50458-606-01 |
410 mg paliperidone palmitate | 1.32 mL | 50458-607-01 |
546 mg paliperidone palmitate | 1.75 mL | 50458-608-01 |
819 mg paliperidone palmitate | 2.63 mL | 50458-609-01 |
1 | INVEGA TRINZA (paliperidone palmitate) extended-release injectable suspension [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+TRINZA-pi.pdf |
2 |